ATOSSA THERAPEUTICS, INC. Increase (Decrease) in Restricted Cash
ATOSSA THERAPEUTICS, INC. (ATOS) reported Increase (Decrease) in Restricted Cash of -$220.00 thousand for the 12-month period ending 2016-12-31, per its 10-K/A filed 2017-03-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2015-12-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2014-12-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2016 was -$220.00K, a 180.00% decline from fiscal 2015.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2015 was $275.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $0.00 derived: sum of 2 quarters · filed 2017-03-21 | -$220.00K 10-K/A · filed 2017-03-21 | |
| 2016-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | -$220.00K 10-Q/A · filed 2017-03-21 | ||
| 2016-06-30 | -$220.00K 10-Q/A · filed 2017-03-21 | |||
| 2015-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $275.00K 10-K/A · filed 2017-03-21 | ||
| 2015-09-30 | $275.00K 10-Q/A · filed 2017-03-21 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |